Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tag: inline UV monitoring SOP biosimilars

Biosimilars: SOP for Creation of Master Cell Bank (MCB) – V 2.0

Posted on By

Biosimilars: SOP for Creation of Master Cell Bank (MCB) – V 2.0 Standard Operating Procedure for Creation of Master Cell Bank (MCB) in Biosimilars Department Biosimilars SOP No. SOP/BS/024/2025 Supersedes SOP/BS/024/2022 Page No. Page 1 of 14 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To outline the procedure for the preparation,…

Read More “Biosimilars: SOP for Creation of Master Cell Bank (MCB) – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Clone Stability Assessment – V 2.0

Posted on By

Biosimilars: SOP for Clone Stability Assessment – V 2.0 Standard Operating Procedure for Clone Stability Assessment in Biosimilar Cell Line Development Department Biosimilars SOP No. SOP/BS/023/2025 Supersedes SOP/BS/023/2022 Page No. Page 1 of 13 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To define the procedure for evaluating the genetic and phenotypic…

Read More “Biosimilars: SOP for Clone Stability Assessment – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Productivity Testing in Small-Scale Cultures – V 2.0

Posted on By

Biosimilars: SOP for Productivity Testing in Small-Scale Cultures – V 2.0 Standard Operating Procedure for Productivity Testing in Small-Scale Biosimilar Cultures Department Biosimilars SOP No. SOP/BS/022/2025 Supersedes SOP/BS/022/2022 Page No. Page 1 of 13 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To describe the procedure for assessing productivity of biosimilar-expressing cell…

Read More “Biosimilars: SOP for Productivity Testing in Small-Scale Cultures – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Glycosylation Analysis in Clone Selection – V 2.0

Posted on By

Biosimilars: SOP for Glycosylation Analysis in Clone Selection – V 2.0 Standard Operating Procedure for Glycosylation Analysis in Biosimilar Clone Selection Department Biosimilars SOP No. SOP/BS/021/2025 Supersedes SOP/BS/021/2022 Page No. Page 1 of 15 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To define the procedure for analyzing glycosylation profiles of expressed…

Read More “Biosimilars: SOP for Glycosylation Analysis in Clone Selection – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Protein Expression Profiling – V 2.0

Posted on By

Biosimilars: SOP for Protein Expression Profiling – V 2.0 Standard Operating Procedure for Protein Expression Profiling in Biosimilar-Producing Cell Lines Department Biosimilars SOP No. SOP/BS/020/2025 Supersedes SOP/BS/020/2022 Page No. Page 1 of 14 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To define the procedure for evaluating biosimilar protein expression levels in…

Read More “Biosimilars: SOP for Protein Expression Profiling – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for mRNA Transcript Analysis (RT-PCR) – V 2.0

Posted on By

Biosimilars: SOP for mRNA Transcript Analysis (RT-PCR) – V 2.0 Standard Operating Procedure for mRNA Transcript Analysis using RT-PCR in Biosimilar Development Department Biosimilars SOP No. SOP/BS/019/2025 Supersedes SOP/BS/019/2022 Page No. Page 1 of 13 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To define the standard procedure for analyzing mRNA transcripts…

Read More “Biosimilars: SOP for mRNA Transcript Analysis (RT-PCR) – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Southern Blot Analysis – V 2.0

Posted on By

Biosimilars: SOP for Southern Blot Analysis – V 2.0 Standard Operating Procedure for Southern Blot Analysis in Biosimilar Cell Lines Department Biosimilars SOP No. SOP/BS/018/2025 Supersedes SOP/BS/018/2022 Page No. Page 1 of 14 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To define the method for performing Southern blot analysis for confirming…

Read More “Biosimilars: SOP for Southern Blot Analysis – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Gene Copy Number Determination – V 2.0

Posted on By

Biosimilars: SOP for Gene Copy Number Determination – V 2.0 Standard Operating Procedure for Gene Copy Number Determination in Biosimilar Cell Lines Department Biosimilars SOP No. SOP/BS/017/2025 Supersedes SOP/BS/017/2022 Page No. Page 1 of 13 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To establish a standardized method for determining the gene…

Read More “Biosimilars: SOP for Gene Copy Number Determination – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Adaptation of Cells to Serum-Free Media – V 2.0

Posted on By

Biosimilars: SOP for Adaptation of Cells to Serum-Free Media – V 2.0 Standard Operating Procedure for Adaptation of Cells to Serum-Free Media in Biosimilar Development Department Biosimilars SOP No. SOP/BS/016/2025 Supersedes SOP/BS/016/2022 Page No. Page 1 of 12 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To describe the step-by-step procedure for…

Read More “Biosimilars: SOP for Adaptation of Cells to Serum-Free Media – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Stable Cell Line Development – V 2.0

Posted on By

Biosimilars: SOP for Stable Cell Line Development – V 2.0 Standard Operating Procedure for Stable Cell Line Development in Biosimilar R&D Department Biosimilars SOP No. SOP/BS/015/2025 Supersedes SOP/BS/015/2022 Page No. Page 1 of 14 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To establish a standardized procedure for the development of stable…

Read More “Biosimilars: SOP for Stable Cell Line Development – V 2.0” »

Biosimilars V 2.0

Posts pagination

1 2 3 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme